Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Guangshengtang updates the inquiry letter response document regarding the issuance of shares to specific targets; the matter still requires approval from the Shenzhen Stock Exchange and registration with the China Securities Regulatory Commission.
Log in to the Sina Finance app and search for 【Disclosure】 to view more assessment grades
Fujian Guangshengtang Pharmaceutical Co., Ltd. (Security Code: 300436, Stock Short Name: Guangshengtang) issued an announcement on March 25, disclosing that, in accordance with the Shenzhen Stock Exchange (hereinafter referred to as the “SZSE”)’s further review opinions in the second round of the audit inquiry letter, the company, together with relevant intermediary institutions, supplemented and updated certain contents in application documents such as the company’s replies to the second round of inquiry letter.
According to the announcement, on February 6, 2026, the company received from the SZSE the “Second Round Audit Inquiry Letter on Fujian Guangshengtang Pharmaceutical Co., Ltd.’s Application for a Stock Offering to Specific Targets” (Audit Inquiry Letter No.〔2026〕020012). The company had previously disclosed its reply to the inquiry letter and related announcement documents on February 11, 2026 on the Cninfo website. This time, based on the SZSE’s further audit opinions, the company has supplemented and updated the relevant contents of the application documents; the specific content was disclosed on the Cninfo website on the same day.
The company emphasizes that this proposed stock offering to specific targets still needs to pass the SZSE’s review and can only be implemented after obtaining approval for registration from the China Securities Regulatory Commission (hereinafter referred to as the “CSRC”). Whether the company will ultimately pass the SZSE’s review and receive the CSRC’s decision to approve registration, as well as the timing of such decision, remain uncertain. The company will promptly fulfill its information disclosure obligations based on the progress of this matter.
Click to view the full text of the announcement>>
Statement: The market involves risk; investment requires caution. This article is automatically published by an AI large model based on third-party databases and does not represent opinions from Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there are any discrepancies, please refer to the actual announcement. If you have any questions, please contact biz@staff.sina.com.cn.
For abundant information and precise interpretation—right on the Sina Finance app
Responsible editor: Xiao Lang Express News